Article Details

Sana Biotechnology: SC291 Moving Forward Beyond Hematological Malignancies

Retrieved on: 2024-01-05 20:20:32

Tags for this article:

Click the tags to see associated articles and topics

Sana Biotechnology: SC291 Moving Forward Beyond Hematological Malignancies. View article details on HISWAI: https://seekingalpha.com/article/4661377-sana-biotechnology-sc291-moving-forward-beyond-hematological-malignancies%3Fsource%3Dcontent_type%253Areact%257Csection_asset%253Arelated-analysis%257Csection%253Aright_rail%257Cfirst_level_url%253Aarticle%257Cline%253A2%257Cpos%253Aundefined

Excerpt

Sana Biotechnology, Inc. phase 1 study results for SC291 and SC262 offer hope for patients with B-cell lymphomas and other disease.

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up